PL3621596T3 - Tabletki z wektorami kwasów nukleinowych - Google Patents

Tabletki z wektorami kwasów nukleinowych

Info

Publication number
PL3621596T3
PL3621596T3 PL18738197.5T PL18738197T PL3621596T3 PL 3621596 T3 PL3621596 T3 PL 3621596T3 PL 18738197 T PL18738197 T PL 18738197T PL 3621596 T3 PL3621596 T3 PL 3621596T3
Authority
PL
Poland
Prior art keywords
tablets
nucleic acid
acid vectors
vectors
nucleic
Prior art date
Application number
PL18738197.5T
Other languages
English (en)
Inventor
Virginie BUSIGNIES-GODDIN
Pascal Bigey
Christine Charrueau
Virginie Escriou
Pierre Tchoreloff
Original Assignee
Université De Bordeaux
Centre National De La Recherche Scientifique
Institut Polytechnique De Bordeaux
Ecole Nationale Supérieure D'arts Et Métiers
Université Paris Cité
Paris Sciences Et Lettres
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59974512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3621596(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Université De Bordeaux, Centre National De La Recherche Scientifique, Institut Polytechnique De Bordeaux, Ecole Nationale Supérieure D'arts Et Métiers, Université Paris Cité, Paris Sciences Et Lettres, Institut National de la Santé et de la Recherche Médicale filed Critical Université De Bordeaux
Publication of PL3621596T3 publication Critical patent/PL3621596T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18738197.5T 2017-05-10 2018-05-09 Tabletki z wektorami kwasów nukleinowych PL3621596T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1754105A FR3066115B1 (fr) 2017-05-10 2017-05-10 Comprimes de vecteurs d'acides nucleiques
PCT/EP2018/062141 WO2018206723A1 (fr) 2017-05-10 2018-05-09 Comprimes de vecteurs d'acides nucleiques

Publications (1)

Publication Number Publication Date
PL3621596T3 true PL3621596T3 (pl) 2022-10-24

Family

ID=59974512

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18738197.5T PL3621596T3 (pl) 2017-05-10 2018-05-09 Tabletki z wektorami kwasów nukleinowych

Country Status (8)

Country Link
US (1) US20200163879A1 (pl)
EP (1) EP3621596B1 (pl)
JP (3) JP2020519691A (pl)
DK (1) DK3621596T3 (pl)
ES (1) ES2913778T3 (pl)
FR (1) FR3066115B1 (pl)
PL (1) PL3621596T3 (pl)
WO (1) WO2018206723A1 (pl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2564525A (en) * 1946-07-15 1951-08-14 Locke Stove Company Cook stove
US2724173A (en) * 1950-06-12 1955-11-22 Girard Alexandre Auguste Leon Method of manufacturing pressure chambers
JPH0278623A (ja) * 1988-09-14 1990-03-19 Sawai Seiyaku Kk インターフェロン誘起剤
JPH11335269A (ja) 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
EP1083886B1 (en) 1998-05-27 2003-04-02 Euroceltique S.A. Drug delivery system comprising a tightly compacted solid medicament stock
AU2001264317A1 (en) * 2000-06-20 2002-01-02 Koken Co., Ltd. Preparations for oligonucleotide transfer
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
AU2003237894A1 (en) 2002-05-20 2003-12-12 Oradel Medical Ltd. Liposome drug delivery
EP1920765A1 (en) * 2006-11-07 2008-05-14 Medigene AG Liposome preparation by single-pass process
CA2926792C (en) 2013-08-13 2021-12-07 Baylor College Of Medicine A novel plga-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
WO2015063615A2 (en) * 2013-11-04 2015-05-07 Meads Chris Stanley System, method, and computer readable medium for calculating mixed frequency valuation changes of illiquid assets
JP2017507946A (ja) 2014-02-26 2017-03-23 エスリス ゲーエムベーハーｅｔｈｒｉｓ ＧｍｂＨ Ｒｎａを胃腸内投与するための組成物

Also Published As

Publication number Publication date
ES2913778T3 (es) 2022-06-06
DK3621596T3 (da) 2022-05-23
FR3066115A1 (fr) 2018-11-16
EP3621596B1 (fr) 2022-02-23
JP2024074832A (ja) 2024-05-31
JP2020519691A (ja) 2020-07-02
WO2018206723A1 (fr) 2018-11-15
FR3066115B1 (fr) 2019-06-28
EP3621596A1 (fr) 2020-03-18
US20200163879A1 (en) 2020-05-28
JP2023014439A (ja) 2023-01-30

Similar Documents

Publication Publication Date Title
IL278000B (en) Synthetic nucleic acid transcripts
HK1248284A1 (zh) 多重乳液核酸擴增
IL254000A0 (en) Nucleic acid sequence composition
IL271239B1 (en) A method for developing nucleic acids
GB201507119D0 (en) Nucleic Acid Construct
HK1243958A1 (zh) 核酸構建體
EP3409780A4 (en) NUCLEIC ACID COMPLEX
HK1244021A1 (zh) 核酸構建體
GB201507115D0 (en) Nucleic Acid Construct
GB201507111D0 (en) Nucleic acid construct
GB201509578D0 (en) Vectors
SG10201600867XA (en) Nucleic acid extracting device
GB2558492B (en) Array antenna
GB201408841D0 (en) Nucleic acid processing
EP3366773A4 (en) NUCLEIC ACID COMPLEX
HK1250682A1 (zh) 核酸擴增
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
GB201812474D0 (en) Nucleic acid construct
SG11201803509XA (en) Magnetic-anchored robotic system
LT3645717T (lt) Moduliniai nukleorūgščių adapteriai
GB201509881D0 (en) Complementary vectors
GB201513300D0 (en) Antenna Array
PL3621596T3 (pl) Tabletki z wektorami kwasów nukleinowych
GB2545291B (en) Robotic system
IL271510A (en) Determining the ratio between nucleic acids